Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany N Caza

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Kidney International|January 21, 2023
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitusTiffany N Caza, Christopher P Larsen
Clinical Kidney Journal|June 1, 2023
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanismsTiffany N Caza, Kenar D Jhaveri
Kidney360|February 23, 2023
Serologic Studies in Membranous Nephropathy: Novel Strategies and Strengthened AssociationsTiffany N Caza, Christopher P Larsen
Kidney International|January 23, 2022
Lipoic acid in neural epidermal growth factor-like 1-associated membranous nephropathy: more than a coincidence?Tiffany N Caza, Christopher P Larsen
Kidney International Reports|July 31, 2024
Clinicopathologic Features of Kidney Disease in Patients With Cystic FibrosisTiffany N Caza, Patrick D Walker
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2024
"Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?Vanja Ivković, Andreas Kronbichler, Tiffany N Caza
Clinical Immunology (Orlando, Fla.)|July 28, 2012
Metabolic regulation of organelle homeostasis in lupus T cellsTiffany N Caza, Gergely Talaber, Andras Perl
Kidney International Reports|June 13, 2022
What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?Tiffany N Caza, Laith F Al-Rabadi
Kidney360|April 4, 2022
Renal Manifestations of Common Variable ImmunodeficiencyTiffany N Caza, Samar I Hassen, Christopher P Larsen
Kidney International|August 22, 2025
Concurrent fibrillary glomerulopathy and amyloidosis: a diagnostic challengeTiffany N Caza, Alejandro Best-Rocha, Christopher P Larsen
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Kidney International|January 21, 2023
False-positive anti-PLA2R ELISA testing in patients with diabetes mellitusTiffany N Caza, Christopher P Larsen
Clinical Kidney Journal|June 1, 2023
Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanismsTiffany N Caza, Kenar D Jhaveri
Kidney360|February 23, 2023
Serologic Studies in Membranous Nephropathy: Novel Strategies and Strengthened AssociationsTiffany N Caza, Christopher P Larsen
Kidney International|January 23, 2022
Lipoic acid in neural epidermal growth factor-like 1-associated membranous nephropathy: more than a coincidence?Tiffany N Caza, Christopher P Larsen
Kidney International Reports|July 31, 2024
Clinicopathologic Features of Kidney Disease in Patients With Cystic FibrosisTiffany N Caza, Patrick D Walker
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 11, 2024
"Atypical" Anti-GBM Disease: Just Atypical, or Not Anti-GBM Disease at All?Vanja Ivković, Andreas Kronbichler, Tiffany N Caza
Clinical Immunology (Orlando, Fla.)|July 28, 2012
Metabolic regulation of organelle homeostasis in lupus T cellsTiffany N Caza, Gergely Talaber, Andras Perl
Kidney International Reports|June 13, 2022
What Can Mercury Teach Us About Membranous Nephropathy and Minimal Change Disease?Tiffany N Caza, Laith F Al-Rabadi
Kidney360|April 4, 2022
Renal Manifestations of Common Variable ImmunodeficiencyTiffany N Caza, Samar I Hassen, Christopher P Larsen
Kidney International|August 22, 2025
Concurrent fibrillary glomerulopathy and amyloidosis: a diagnostic challengeTiffany N Caza, Alejandro Best-Rocha, Christopher P Larsen
Pageof 5